Evidence map›Paper›PMID 32312759›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2020

Serum Metabolomic Response to Low- and High-Dose Vitamin E Supplementation in Two Randomized Controlled Trials.

Jiaqi Huang, Howard N Hodis, Stephanie J Weinstein, Wendy J Mack, Joshua N Sampson, Alison M Mondul, Demetrius Albanes

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Scientific opinion on the tolerable upper intake level for vitamin E.EFSA journal. European Food Safety Authority · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jiaqi HuangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland. jiaqi.huang@nih.gov daa@nih.gov.
Howard N HodisAtherosclerosis Research Unit, Department of Preventive Medicine, Keck School of Medicine, University of Southern California (USC), Los Angeles, California.
Stephanie J WeinsteinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland.ORCID 0000-0002-3834-1535
Wendy J MackAtherosclerosis Research Unit, Department of Preventive Medicine, Keck School of Medicine, University of Southern California (USC), Los Angeles, California.
Joshua N SampsonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland.ORCID 0000-0003-2875-3365
Alison M MondulDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.
Demetrius AlbanesDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland. jiaqi.huang@nih.gov daa@nih.gov.
National Institutes of Health · USUniversity of Southern California · USUniversity of Michigan · US

Funding

Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) StudyZIACP010195 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ALBANES, DEMETRIUS · 2009 to 2025
$22.5M
Drug Treatment of Ethanol Seeking in Rat and MonkeyR01AA013860 · NIAAA · BROWN UNIVERSITY · PI CZACHOWSKI, CRISTINE L · 2003 to 2006
$918k
ALPHA-TOCOPHEROL, BETA-CAROTENE CANCER PREVENTION STUDY AND COHORT FOLLOW-UPZ01SC000100 · SC · CLINICAL SCIENCES · PI ALBANES, D · 1999 to 2002
–
Intramural NIH HHS Z01 SC000100NIAAA NIH HHS R01 AA013860
6 · The paper itself

Abstract

backgroundVitamin E is an essential micronutrient and critical human antioxidant previously tested for cancer preventative effects with conflicting clinical trial results that have yet to be explained biologically.

methodsWe examined baseline and on-trial serum samples for 154 men randomly assigned to receive 400 IU vitamin E (as alpha-tocopheryl acetate; ATA) or placebo daily in the Vitamin E Atherosclerosis Prevention Study (VEAPS), and for 100 men administered 50 IU ATA or placebo daily in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC). Over 970 metabolites were identified using ultrahigh-performance LC/MS-MS. Linear regression models estimated the change in serum metabolites of men supplemented with vitamin E versus those receiving placebo in VEAPS as compared with ATBC.

resultsSerum alpha-carboxyethyl hydrochroman (CEHC) sulfate, alpha-tocopherol, and beta/gamma-tocopherol were significantly altered by ATA supplementation in both trials (all

conclusionsWe found evidence of a dose-dependent vitamin E supplementation effect on a novel C IMPACT: Our data add information on a differential hormonal response based on vitamin E dose that could have direct relevance to opposing prostate cancer incidence results from previous large controlled trials.

Indexed as

Dietary SupplementsDouble-Blind MethodFemaleHumansMaleMetabolomicsMiddle AgedVitamin EVitamin E

Identifiers

PMID32312759
PMCPMC7340214
OpenAlexW3017161132

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.